3-pyridine toxoflavin

CAS No. 32502-20-8

3-pyridine toxoflavin( —— )

Catalog No. M35948 CAS No. 32502-20-8

3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 427 Get Quote
10MG 626 Get Quote
25MG 908 Get Quote
50MG 1279 Get Quote
100MG 1692 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-pyridine toxoflavin
  • Note
    Research use only, not for human use.
  • Brief Description
    3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.
  • Description
    3-Pyridine toxoflavin (compound 49) is a PIN1 inhibitor. 3-Pyridine toxoflavin can be used for the research of immune disease proliferative disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32502-20-8
  • Formula Weight
    270.25
  • Molecular Formula
    C12H10N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2C(N(C)N=C(N2)C=3C=CN=CC3)=NC(=O)N1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. LU, Kun Ping, et al. Methods and compositions for the inhibition of pin1. US20150133442. 2014.
molnova catalog
related products
  • DDP-38003 dihydrochl...

    DDP-38003 is an novel, orally available inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) with IC50 of 84 nM.

  • MRTX9768

    MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.

  • SAH-EZH2

    EZH2/EPP interaction inhibitor (Kd = 320 nM). Suppresses EZH2 expression and H3K27 trimethylation by PCR2 complex. Arrests proliferation and induces monocyte to macrophage differentiation of MLL-AF9 leukemia cell line.